On-demand hyoscine butylbromide for the treatment of self-reported functional cramping abdominal pain

References

• Pomeroy AR, Rand MJ. Anticholinergic effects and passage through the intestinal wall of N-butyl hyoscine bromide. J Pharm Pharmacol 1969;21:180–7.
   PubMed Web of Science ®Google Scholar
• Bommelaer G, Poynard T, Le Pen C, Gaudin AF, Maurel F, Priol G, et al. Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol 2004;28:554–61.
   PubMed Web of Science ®Google Scholar
• Quigley EMM, Locke GR, Mueller-Lissner S, Paulo LG, Tytgat GN, Helfrich I, et al. Prevalence and management of abdominal cramping and pain: a multinational survey. Aliment Pharmacol Ther 2006;24:411–19.
   PubMed Web of Science ®Google Scholar
• Sandler RS, Stewart WF, Liberman JN, Ricci JA, Zorich NL. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci 2000;45:1166–71.
   PubMed Web of Science ®Google Scholar
• Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Mueller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45:43–7.
   Web of Science ®Google Scholar
• Nigam P, Kapoor KK, Rastog CK, Kumar A, Gupta AK. Different therapeutic regimens in irritable bowel syndrome. J Assoc Physicians India 1984;32:1041–4.
   PubMedGoogle Scholar
• Ritchie JA, Truelove SC. Treatment of irritable bowel syndrome with lorazepam, HBB butylbromide and ispaghula husk. Br Med J 1979;1:376–8.
   PubMed Web of Science ®Google Scholar
• Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008;337:a2313. Erratum in: BMJ.2009;338:b1881.
   PubMed Web of Science ®Google Scholar
• Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomised, controlled trials. Ann Intern Med 2000;133:136–47.
   PubMed Web of Science ®Google Scholar
• Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001;15:355–61.
   PubMed Web of Science ®Google Scholar
• Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, de Wit N. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome (review). Cochrane Database Syst Rev 2005;2:CD0033460.
   Google Scholar
• Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45:II69–77.
   PubMed Web of Science ®Google Scholar
• Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006;130:1538–51.
   PubMed Web of Science ®Google Scholar
• Mueller-Lissner S, Tytgat GN, Paulo LG, Quigley EMM, Bubeck J, Peil H, et al. Placebo- and paracetamol-controlled study on the efficacy and tolerability of HBB butylbromide in the treatment of patients with recurrent crampy abdominal pain. Aliment Pharmacol Ther 2006;23:1741–8.
   PubMed Web of Science ®Google Scholar
• Schaefer E, Ewe K. Treatment of irritable bowel syndrome: efficacy and tolerance of Buscopan plus, Buscopan, paracetamol and placebo in ambulatory patients with IBS. Fortschr Med 1990;108:488–92.
   PubMedGoogle Scholar
• Tytgat GN. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs 2007;67:1343–57.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Richter JE, Talley NJ, Thompson WG, Corraziari E, Whitehead WE. The functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment – a multinational consensus. Boston: Little, Brown; 1994. pp 370.
   Google Scholar
• Manning AP, Thompson WG, Heaton KE, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2:653–4.
   PubMed Web of Science ®Google Scholar
• Evangelista S. Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome. Curr Pharm Des 2004;10:3561–8.
   PubMed Web of Science ®Google Scholar
• Ge Z, Yuan Y, Zhang S, Hou X, Wang J, Cai J, et al. Efficacy and tolerability of two oral hyoscine butylbromide formulations in Chinese patients with recurrent episodes of self-reported gastric or intestinal spasm-like pain. Int J Clin Pharmacol Ther 2011;49:198–205.
   PubMed Web of Science ®Google Scholar
• Mertz HR. Irritable bowel syndrome. N Engl J Med 2003;349:2136–46.
   PubMed Web of Science ®Google Scholar
• Hungin APS, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 patients. Aliment Pharmacol Ther 2003;17:643–50.
   PubMed Web of Science ®Google Scholar